AI-PROGNOSIS was introduced at Dreiländertagung 2025, the joint annual meeting of the German and Austrian Societies for Epileptology and the Swiss Epilepsy League, held in Salzburg, Austria (26–29 March 2025).

Dr. Arnfin Bergmann MD and Niloofar Tavakoli from NeuroTransData GmbH engaged with congress participants to present the AI-PROGNOSIS project and its approach to using artificial intelligence and digital biomarkers to support improved care for Parkinson’s disease.

While the event primarily focused on epilepsy, it also brought together neurologists from a range of fields — creating a great opportunity to share the project’s goals with experts involved in Parkinson’s and other neurological conditions.